Dj Biotech Profile
Key Indicators
- Authorised Capital ₹ 7.00 M
as on 16-06-2024
- Paid Up Capital ₹ 6.96 M
as on 16-06-2024
- Company Age 19 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 2.77 Cr
as on 16-06-2024
- Revenue 21955.39%
(FY 2021)
- Profit 879.52%
(FY 2021)
- Ebitda -654.73%
(FY 2021)
- Net Worth 7561.97%
(FY 2021)
- Total Assets 1.39%
(FY 2021)
About Dj Biotech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.00 M and a paid-up capital of Rs 6.96 M.
The company has closed loans amounting to ₹2.77 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Vivek Goyal and Naresh Goyal serve as directors at the Company.
- CIN/LLPIN
U02423HP2005PTC031114
- Company No.
031114
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Apr 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Himachal Pradesh
Industry
Company Details
- Location
Tehsil Haroli, Himachal Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Dj Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vivek Goyal  | Additional Director | 17-Feb-2008 | Current |
| Naresh Goyal | Additional Director | 23-Jun-2021 | Current |
Financial Performance of Dj Biotech.
Dj Biotech Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 21955.39% increase. The company also saw a substantial improvement in profitability, with a 879.52% increase in profit. The company's net worth Soared by an impressive increase of 7561.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dj Biotech?
In 2021, Dj Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Maiden Pharmaceuticals LimitedActive 34 years 1 monthVivek Goyal and Naresh Goyal are mutual person
- Shree Bhagwati Credit Portfolios Private LimitedActive 31 years 8 months
Vivek Goyal is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of Patiala Creation Date: 16 Dec 2005 | ₹2.77 Cr | Satisfied |
How Many Employees Work at Dj Biotech?
Dj Biotech has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dj Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dj Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
